| Entry |
|
|---|
| Name |
Tranylcypromine (INN);
Parnate (TN) |
|---|
| Formula |
C9H11N
|
|---|
| Exact mass |
133.0891
|
|---|
| Mol weight |
133.1903
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
|
|---|
| Remark |
| Product (DG00949): | D00826<US> |
|
|---|
| Efficacy |
Antidepressant, Monoamine oxidase (MAO) inhibitor |
|---|
| Target |
|
|---|
| Pathway |
| hsa00260 | Glycine, serine and threonine metabolism |
| hsa00330 | Arginine and proline metabolism |
| hsa00982 | Drug metabolism - cytochrome P450 |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07216 | Catecholamine transferase inhibitors |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N06 PSYCHOANALEPTICS
N06A ANTIDEPRESSANTS
N06AF Monoamine oxidase inhibitors, non-selective
N06AF04 Tranylcypromine
D08625 Tranylcypromine (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
DG00949 Tranylcypromine
D08625 Tranylcypromine
Target-based classification of drugs [BR:br08310]
Enzymes
Oxidoreductases (EC1)
Amine oxidases
MAO
D08625 Tranylcypromine (INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01568 MAO inhibitor
DG01519 Non-selective monoamine oxidase inhibitor
DG00949 Tranylcypromine
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 10
1 C1y C 24.7100 -17.1500
2 C8y C 23.5200 -17.8500
3 C1y C 26.1100 -17.1500
4 C1x C 25.4100 -15.8900
5 C8x C 22.2600 -17.1500
6 C8x C 23.5200 -19.2500
7 N1a N 27.3000 -17.8500
8 C8x C 21.0700 -17.8500
9 C8x C 22.2600 -19.9500
10 C8x C 21.0700 -19.2500
BOND 11
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1 #Up
7 5 8 1
8 6 9 2
9 8 10 2
10 3 4 1
11 9 10 1
|
|---|
